A Single-center Retrospective Study of Clinical Features, Treatment Patterns, and Survival of Sarcomas
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
The clinical data of all eligible patients who received chemotherapy, radiotherapy, targeted therapy, immunotherapy, interventional therapy and surgery in Henan Tumor Hospital from June 1, 2012 to May 30, 2022 were retrospectively collected.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 6
Maximum Age: 99
Healthy Volunteers: f
View:
• No age limit, male or female. A certain subtype of sarcoma was diagnosed by pathology in our hospital. Has received at least one hospitalization in this hospital. Target lesions can be evaluated according to solid tumor efficacy evaluation criteria (RECIST; Version 1.1) Measure diameter changes.
• Complete follow-up data.
Locations
Other Locations
China
Department of Bone and Soft Tissue ,Henan Cancer Hospital
RECRUITING
Zhengzhou
Contact Information
Primary
Wang Jiaqiang, Dr.
wjqwtj@126.com
13592413731
Time Frame
Start Date: 2022-06-07
Estimated Completion Date: 2024-12-31
Participants
Target number of participants: 6000
Related Therapeutic Areas
Sponsors
Leads: Henan Cancer Hospital